KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Levi Strauss (LEVI) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Levi Strauss (LEVI) over the last 16 years, with Q4 2025 value amounting to $693.0 million.

  • Levi Strauss' Cost of Revenue rose 360.29% to $693.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $2.4 billion, marking a year-over-year increase of 123.37%. This contributed to the annual value of $2.4 billion for FY2025, which is 123.37% up from last year.
  • Per Levi Strauss' latest filing, its Cost of Revenue stood at $693.0 million for Q4 2025, which was up 360.29% from $591.8 million recorded in Q3 2025.
  • Levi Strauss' 5-year Cost of Revenue high stood at $746.6 million for Q1 2023, and its period low was $510.7 million during Q4 2023.
  • Over the past 5 years, Levi Strauss' median Cost of Revenue value was $613.2 million (recorded in 2022), while the average stood at $614.9 million.
  • In the last 5 years, Levi Strauss' Cost of Revenue soared by 6034.95% in 2021 and then tumbled by 2718.85% in 2023.
  • Quarter analysis of 5 years shows Levi Strauss' Cost of Revenue stood at $710.4 million in 2021, then dropped by 1.27% to $701.4 million in 2022, then decreased by 27.19% to $510.7 million in 2023, then skyrocketed by 30.98% to $668.9 million in 2024, then increased by 3.6% to $693.0 million in 2025.
  • Its last three reported values are $693.0 million in Q4 2025, $591.8 million for Q3 2025, and $540.2 million during Q2 2025.